The goal of this activity is for learners to be better able to understand and apply data related to new and emerging HER2-targeted therapies in the management of BTC.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/her2-positive-biliary-tract-cancer-new-developments-and-2024a1000lnu
- Start Date: 2024-12-23 06:00:00
- End Date: 2024-12-23 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
- MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Jazz Pharmaceuticals, Inc. - Amount: 94286.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Gastroenterology, Medical Oncology
Subscribe
Login
0 Comments
Oldest